Arwen Podesta
Psychiatry · New Orleans, LANPI 1194914598
Payments from drug & device makers
Across 552 payments — averaging $845.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$146K
- Indivior Inc.$102K
- Braeburn Inc.$65K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$46K
- Axsome Therapeutics, Inc.$44K
- AbbVie$21K
- plus $44K from 22 others
What the payments were for
- Consulting fees$118,22825%
- Speaking & faculty fees$282,53461%
- Travel & lodging$53,38311%
- Food & beverage$12,2053%
- Education$1240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 163 | $145,809 |
| Indivior Inc. | 87 | $101,514 |
| Braeburn Inc. | 91 | $64,929 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 24 | $46,459 |
| Axsome Therapeutics, Inc. | 52 | $43,542 |
| AbbVie | 39 | $20,511 |
| Pear Therapeutics (US), Inc. | 12 | $16,810 |
| Eli Lilly | 6 | $9,888 |
| MDD US Operations, LLC | 16 | $5,512 |
| Boehringer Ingelheim | 1 | $3,350 |
| Sandoz | 1 | $3,319 |
| Otsuka America Pharmaceutical, Inc. | 7 | $1,615 |
| Orexo US, Inc. | 3 | $1,543 |
| Kaleo, Inc. | 1 | $650 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $291 |
| Pfizer | 11 | $164 |
| Idorsia Pharmaceuticals US Inc | 3 | $161 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $66 |
| Biohaven Pharmaceuticals, Inc. | 4 | $59 |
| Shire North American Group Inc | 3 | $55 |
| Johnson & Johnson | 3 | $54 |
| Jazz Pharmaceuticals Inc. | 2 | $42 |
| Lundbeck LLC | 1 | $39 |
| Supernus Pharmaceuticals, Inc. | 1 | $28 |
| Almatica Pharma LLC | 1 | $21 |
| Eisai Inc. | 1 | $15 |
| Adlon Therapeutics L.p. | 1 | $15 |
| Acadia Pharmaceuticals Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$466,474 in reported general payments places this provider in the 95th percentile of 474 psychiatry providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 12 | $2,951 |
| Bupropion XlBupropion Hcl | 22 | $696 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 16 | $612 |
| Baclofen | 23 | $446 |
| Quetiapine Fumarate | 17 | $347 |
| Escitalopram Oxalate | 16 | $251 |
| Duloxetine Hcl | 13 | $246 |
| Trazodone Hcl | 13 | $239 |
| Bupropion Hcl | 13 | $239 |
| Diazepam | 11 | $153 |
| Sertraline Hcl | 24 | $130 |
| Fluoxetine Hcl | 12 | $89 |
| Mirtazapine | 11 | $77 |
| Gabapentin | 16 | $49 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $21 | $13024 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 474 psychiatry providers in Louisiana.
Other psychiatry in New Orleans
- Andrew MorsonNew Orleans$56K
- James BarbeeNew Orleans$28K
- Neha KansaraNew Orleans$13K
- Erich ConradNew Orleans$9K
- Rahn BaileyNew Orleans$8K
- Nick RamandiNew Orleans$8K
- Ashley WeissNew Orleans$8K
- Ravindra ReddyNew Orleans$7K
- Paul PeltsNew Orleans$6K
- Janet BradleyNew Orleans$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.